KS

Kayan Sharma

Active Director Additional Director DIN 11281526
DIN 11281526 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Kayan Sharma

Data last updated:

Kayan Sharma is an Additional Director at Medilia Limited (since 2025). The company operates in Pharma. Medilia Limited reported revenue of ₹4,277 (FY 2024).

DIN 11281526
Primary Designation Additional Director
Industry Pharma
First Appointment 12 Sep 2025
Oldest Company Age 5 yrs
Largest company Medilia Limited · ₹4,277 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medilia Limited U24299DL2021PLC381855
Additional Director12 Sep 20252021₹4,277 (FY 2024)Active

Board colleagues of Kayan Sharma

Directorship timeline

Open interactive timeline →
Medilia Limited
Premium access

Shareholding and investment profile for Kayan Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kayan Sharma

Kayan Sharma currently holds 1 directorship: Medilia Limited (Additional Director, since 12 Sep 2025, revenue ₹4,277 (FY 2024)).

Kayan Sharma was first appointed on 12 Sep 2025 as Additional Director at Medilia Limited.

The current boards of Kayan Sharma's companies include Akshay Pramod Gupta (Medilia Limited), Amarjyot Singh Anand (Medilia Limited), Anant Aggarwal (Medilia Limited), Gaurav Rajput (Medilia Limited), Harish Goyal (Medilia Limited), Pratik Pramod Gupta (Medilia Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available